Exploring In‐Silico , In‐Vitro Antioxidant, and Cytotoxic Potential of Valerian wallichii by On Cervical Epithelial Carcinoma (HeLa) Cell Lines
Chemistry & Biodiversity · 2024
DOI: 10.1002/cbdv.202302072 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2024. Verfasst von Sachin Gudasi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacognosy, KLE College of Pharmacy, Belagavi, KLE Academy of Higher Education and Research, Belagavi, 590 010, Karnataka, India. Hauptthemen laut MEDLINE: Valerian, Antineoplastic Agents, Carcinoma. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: KLE College of Pharmacy, Belagavi.
Abstract (Originalsprache)
Traditional medicinal practices often utilize herbal remedies for treating various diseases. This study focuses on exploring the phytochemical constituents, in‐silico , in‐vitro antioxidant, and anticancer activities of Valerian wallichii root extracts on human cervical epithelial carcinoma (HeLa) cell lines. The molecular docking approach was employed to predict the ligand molecule‘s orientation within the receptor like Epidermal growth factor receptor tyrosine kinase domain (PDB ID: 1M17) using Schrodinger's GLIDE model. Among the selected phytocompounds, hesperidin exhibited promising inhibitory activity against EGFR (Epidermal Growth Factor Receptor) domain with −8.701 kcal/mol docking score and interactions with MET 769, ASP 831, ASP776, LEU694 and ASN818 residues as compared to standard doxorubicin with −7.6 kcal/mol docking score and interactions with ASP 831, ASN818 and ASP776 residues and further, various antioxidant activity was assessed and In‐vitro anticancer activity against HeLa cell lines was evaluated by hydroalcoholic root extracts demonstrated antioxidant capacities, and selective cytotoxicity was observed, with IC 50 : 45.759±0.42 μg/mL for the overall extract and IC 50 : 30.245±0.58 μg/mL for the EAF fraction as compared to standard doxorubicin with IC 50 : 25.9891±0.25 μg/mL, respectively. The present study concluded that Valerian wallichii L possesses potential human cervical epithelial carcinoma cell line inhibition properties based on the computer aided drug design models and in‐vitro activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacognosy, KLE College of Pharmacy, Belagavi, KLE Academy of Higher Education and Research, Belagavi, 590 010, Karnataka, India.
- Department of Pharmaceutical Chemistry, KLE College of Pharmacy, Belagavi, KLE Academy of Higher Education and Research, Belagavi, 590 010, Karnataka, India.
- Department of Pharmaceutical Quality Assurance, KLE College of Pharmacy, Belagavi, KLE Academy of Higher Education and Research, Belagavi, 590 010, Karnataka, India.
ORCID-Profile: Sachin Gudasi, Shankar Gharge, Rahul Koli, Pooja Kagawad
Förderung
- KLE College of Pharmacy, Belagavi
Zitieren
APA
Gudasi, S., Gharge, S., Koli, R., & Kagawad, P. (2024). Exploring In‐Silico , In‐Vitro Antioxidant, and Cytotoxic Potential of Valerian wallichii by On Cervical Epithelial Carcinoma (HeLa) Cell Lines. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202302072
Vancouver
Gudasi S, Gharge S, Koli R, Kagawad P. Exploring In‐Silico , In‐Vitro Antioxidant, and Cytotoxic Potential of Valerian wallichii by On Cervical Epithelial Carcinoma (HeLa) Cell Lines. Chemistry & Biodiversity. 2024. doi:10.1002/cbdv.202302072
BibTeX
@article{Gudasi2024,
author = {Gudasi, Sachin and Gharge, Shankar and Koli, Rahul and Kagawad, Pooja},
title = {Exploring In‐Silico , In‐Vitro Antioxidant, and Cytotoxic Potential of Valerian wallichii by On Cervical Epithelial Carcinoma (HeLa) Cell Lines},
journal = {Chemistry & Biodiversity},
year = {2024},
doi = {10.1002/cbdv.202302072}
}
EUVIMED